Single-dose plasma pharmacokinetic analysis of targeted anticancer agents in tumor-bearing dogs
condition(s)
malignant neoplasia
eligibility information
Enrollment Deadline
Enrollment ends June 2, 2025
Enrollment ends June 2, 2025